Terms: = Leukemia AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
5 results:
1. Effect of hsp90ab1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells.
Peng Y; Huang Z; Zhou F; Wang T; Mou K; Feng W
Cell Commun Signal; 2021 Jul; 19(1):71. PubMed ID: 34217296
[TBL] [Abstract] [Full Text] [Related]
2. PML/RARA inhibits expression of HSP90 and its target AKT.
Piredda ML; Gaur G; Catalano G; Divona M; Banella C; Travaglini S; Puzzangara MC; Voso MT; Lo-Coco F; Noguera NI
Br J Haematol; 2019 Mar; 184(6):937-948. PubMed ID: 30536958
[TBL] [Abstract] [Full Text] [Related]
3. Secondary head and neck cancer in patients with history of hematological malignancy.
Chung JC; Tsang RK; To VS; Ho AC; Chan JY; Ho WK; Wei WI
Head Neck; 2013 May; 35(5):729-32. PubMed ID: 22585675
[TBL] [Abstract] [Full Text] [Related]
4. An automated method for supporting busulfan therapeutic drug monitoring.
Juenke JM; Miller KA; McMillin GA; Johnson-Davis KL
Ther Drug Monit; 2011 Jun; 33(3):315-20. PubMed ID: 21544019
[TBL] [Abstract] [Full Text] [Related]
5. [Heat shock activated Rac-MEKK-JNK pathway and hsp90 beta gene expression].
Li XY; Lu C; Wu NH; Shen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):264-8. PubMed ID: 12905631
[TBL] [Abstract] [Full Text] [Related]